Will Functional Genomics Cure Big Pharma’s Failure Rate?

Drug discovery is a notoriously expensive and inefficient endeavor. Nine of 10 drug candidates that go through the cost-intensive, years-long clinical trial process never make it to market. That 90% failure rate–a drag on medical progress and a factor often cited by pharmaceutical companies to justify sky-high drug prices–has proven frustratingly sticky even in an […]